How does positive p53 staining influence your recommendation for adjuvant therapy in comprehensively staged early (stage IA or IB), grade 2, endometrioid endometrial cancers?

If patient meets high intermediate risk criteria, would you consider chemotherapy in addition to radiation?

Answer from: Medical Oncologist at Community Practice

It does not influence my recommendations. If a study is available to potential study the risk conferred by P53, I would offer it to my patient.